X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2479) 2479
Publication (168) 168
Newsletter (54) 54
Book Review (53) 53
Book Chapter (12) 12
Magazine Article (11) 11
Newspaper Article (7) 7
Conference Proceeding (6) 6
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1920) 1920
itraconazole (1740) 1740
male (1127) 1127
antifungal agents - therapeutic use (1042) 1042
female (1007) 1007
index medicus (824) 824
adult (801) 801
middle aged (750) 750
itraconazole - therapeutic use (697) 697
antifungal agents - adverse effects (577) 577
antifungal agents - administration & dosage (569) 569
pharmacology & pharmacy (549) 549
fluconazole (486) 486
aged (463) 463
treatment outcome (427) 427
itraconazole - administration & dosage (396) 396
itraconazole - adverse effects (391) 391
administration, oral (363) 363
drug interactions (355) 355
voriconazole (347) 347
dermatology (331) 331
infectious diseases (310) 310
antifungal agents (308) 308
adolescent (307) 307
mycoses (304) 304
pharmacokinetics (284) 284
animals (276) 276
amphotericin-b (260) 260
therapy (255) 255
terbinafine (250) 250
microbiology (233) 233
antifungal agents - pharmacology (210) 210
mycoses - drug therapy (208) 208
child (205) 205
aspergillosis - drug therapy (204) 204
onychomycosis - drug therapy (203) 203
drug therapy (202) 202
aspergillosis (198) 198
amphotericin b - therapeutic use (196) 196
ketoconazole (195) 195
antifungal agents - pharmacokinetics (194) 194
care and treatment (192) 192
immunology (192) 192
double-blind (184) 184
transplantation (184) 184
onychomycosis (183) 183
fluconazole - therapeutic use (182) 182
health aspects (181) 181
posaconazole (174) 174
drug therapy, combination (171) 171
medicine & public health (162) 162
mycology (161) 161
mycoses - prevention & control (158) 158
triazoles - therapeutic use (157) 157
diagnosis (154) 154
fungal-infections (154) 154
amphotericin b (150) 150
risk factors (150) 150
analysis (149) 149
drug administration schedule (146) 146
infection (146) 146
young adult (146) 146
itraconazole - pharmacology (145) 145
medicine, general & internal (141) 141
research (141) 141
fungal infections (140) 140
infections (139) 139
oncology (138) 138
ketoconazole - therapeutic use (135) 135
dose-response relationship, drug (128) 128
efficacy (127) 127
safety (127) 127
veterinary sciences (127) 127
retrospective studies (126) 126
immunocompromised host (122) 122
triazoles - adverse effects (120) 120
prophylaxis (119) 119
invasive aspergillosis (114) 114
dosage and administration (113) 113
fungi (112) 112
in-vitro (112) 112
dermatology & venereal diseases (111) 111
triazoles - administration & dosage (111) 111
double-blind method (110) 110
internal medicine (110) 110
pharmacology/toxicology (110) 110
drugs (109) 109
itraconazole - pharmacokinetics (109) 109
hematology (108) 108
invasive fungal-infections (108) 108
prospective studies (108) 108
cancer (106) 106
microbial sensitivity tests (106) 106
naphthalenes - therapeutic use (105) 105
epidemiology (104) 104
ketoconazole - analogs & derivatives (102) 102
liposomal amphotericin-b (101) 101
area under curve (100) 100
child, preschool (99) 99
metabolism (98) 98
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2414) 2414
Japanese (30) 30
Spanish (28) 28
French (27) 27
German (19) 19
Chinese (11) 11
Dutch (11) 11
Korean (5) 5
Russian (4) 4
Finnish (3) 3
Italian (3) 3
Polish (2) 2
Bulgarian (1) 1
Czech (1) 1
Danish (1) 1
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 06/2019, Volume 79, Issue 8, pp. 833 - 853
Journal Article
Current Medical Research & Opinion, ISSN 0300-7995, 01/2013, Volume 29, Issue 1, pp. 1 - 12
Abstract Background: Rifampin is a potent inducer of both cytochrome P-450 oxidative enzymes and the P-glycoprotein transport system. Among numerous well... 
Rifabutin | Rifampin | Rifapentine | Drug interactions | MEDICINE, RESEARCH & EXPERIMENTAL | ENZYME-INDUCTION | PLATELET-AGGREGATION | TUBERCULOSIS | OPEN-LABEL | ATORVASTATIN | SINGLE-BLIND | MEDICINE, GENERAL & INTERNAL | PHARMACOKINETICS | PLASMA-CONCENTRATIONS | HEALTHY-VOLUNTEERS | TRANSPORTER INHIBITION | Rifampin - analogs & derivatives | Simvastatin - therapeutic use | Antifungal Agents - adverse effects | Digoxin - adverse effects | Simvastatin - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antifungal Agents - therapeutic use | Rifampin - adverse effects | Verapamil - therapeutic use | Drug Interactions | Verapamil - adverse effects | Rifampin - therapeutic use | Contraceptives, Oral - adverse effects | Contraceptives, Oral - therapeutic use | Digoxin - therapeutic use | HIV Protease Inhibitors - adverse effects | Rifabutin - adverse effects | Anti-Arrhythmia Agents - therapeutic use | HIV Protease Inhibitors - therapeutic use | Anticholesteremic Agents - adverse effects | Itraconazole - therapeutic use | Anticholesteremic Agents - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Itraconazole - adverse effects | Antibiotics, Antitubercular - therapeutic use | Cytochrome P-450 Enzyme System - biosynthesis | Rifabutin - therapeutic use | ATP Binding Cassette Transporter, Sub-Family B | Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2007, Volume 356, Issue 4, pp. 348 - 359
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2004, Volume 351, Issue 11, pp. 1089 - 1096
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 08/2016, Volume 63, Issue 3, pp. 356 - 362
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2009, Volume 53, Issue 3, pp. 958 - 966
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CELL TRANSPLANT RECIPIENTS | STEADY-STATE PHARMACOKINETICS | BEVERAGE COCA-COLA | SALVAGE THERAPY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | FOOD INTERACTION | INVASIVE FUNGAL-INFECTION | ITRACONAZOLE | TRIAZOLE ANTIFUNGAL | VERSUS-HOST-DISEASE | FLUCONAZOLE | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Triazoles - blood | Area Under Curve | Humans | Middle Aged | Omeprazole - blood | Intestinal Absorption - drug effects | Male | Anti-Ulcer Agents - blood | Gastric Mucosa - metabolism | Anti-Ulcer Agents - pharmacokinetics | Dose-Response Relationship, Drug | Young Adult | Antifungal Agents - pharmacokinetics | Hydrogen-Ion Concentration - drug effects | Gastric Mucosa - drug effects | Adult | Female | Triazoles - pharmacokinetics | Suspensions | Eating | European Continental Ancestry Group - genetics | Fasting | Drug Administration Schedule | Administration, Oral | Food-Drug Interactions | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | African Americans - genetics | European Continental Ancestry Group - statistics & numerical data | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Carbonated Beverages | Anti-Ulcer Agents - administration & dosage | Cross-Over Studies | African Americans - statistics & numerical data | Antifungal Agents - administration & dosage | Antifungal Agents - blood | Index Medicus | Pharmacology
Journal Article